Philip J. Ebert
Eli Lilly (United States) · 126 works · 4,788 citations · h-index 30
Top works
- Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19
- A genetic variant that disrupts MET transcription is associated with autism
- Immune transcriptome alterations in the temporal cortex of subjects with autism
- Crossinhibitory Activities of Ngn1 and Math1 Allow Specification of Distinct Dorsal Interneurons
- Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regions
- Disruption of cerebral cortex MET signaling in autism spectrum disorder
- Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2− Breast Cancer
- RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion
- The organization of the transcriptional network in specific neuronal classes
- Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study
- Amygdala Gene Expression Correlates of Social Behavior in Monkeys Experiencing Maternal Separation
- Paenibacillus lentus sp. nov., a β-mannanolytic bacterium isolated from mixed soil samples in a selective enrichment using guar gum as the sole carbon source
- Zic1 represses Math1 expression via interactions with the Math1 enhancer and modulation of Math1 autoregulation
- RGS4 is a negative regulator of insulin release from pancreatic β-cells in vitro and in vivo
- A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load
- Making the Case for a Candidate Vulnerability Gene in Schizophrenia: Convergent Evidence for Regulator of G-Protein Signaling 4 (RGS4)
- BrainSeq: Neurogenomics to Drive Novel Target Discovery for Neuropsychiatric Disorders
- N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a Novel Metabotropic Glutamate 2 Potentiator with Potential Anxiolytic/Antidepressant Properties: In Vivo Profiling Suggests a Link between Behavioral and Central Nervous System Neurochemical Changes
- Genomic Characterization of Intrinsic and Acquired Resistance to Cetuximab in Colorectal Cancer Patients
- Gain and Loss of Function of P2X7 Receptors: Mechanisms, Pharmacology and Relevance to Diabetic Neuropathic Pain